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349Abstracts
breast cancer risk, while 11.6% and 14.3% of respondents
believed that they were at higher 5-year and lifetime risk of
breast cancer as compared to an average woman, respectively. A
low but signiﬁcant correlation (0.167, p = 0.045) was found
between respondents’ actual risk and perceived risk of breast
cancer. A large proportion of women (42.6%) were not sure
whether or not they would consume chemopreventive tamoxifen
for breast cancer if advised by their doctor. Only 16.7% women
expressed willingness to consume tamoxifen. No relationship
was found between women’s perceived and actual risk of breast
cancer and their mammography screening behavior or willing-
ness to consume chemopreventive tamoxifen. CONCLUSIONS:
Actual and perceived risk of breast cancer does not seem to be
associated with their screening behavior or willingness to
consume chemopreventive tamoxifen in this population. 
Relatively few women in this population may opt to consume
chemopreventive tamoxifen for reducing their risk of breast
cancer.
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OBJECTIVES: To investigate opioid use in a large sample of
hospice patients and examine differences in opioid use between
cancer and non-cancer patients. METHODS: This project was
conducted with excelleRx, a large hospice pharmacy provider
which contracts with 15% of hospices throughout the US.
Patients included were age 65 or older admitted to hospice
between June 1, 2003 and December 31, 2003. Pharmacy data
through June 30, 2004 was analyzed. Average daily opioid equiv-
alent (ADOE) use was calculated for each patient by converting
total opioid dispensed to morphine equivalents. Associations
between demographic variables and clinical characteristics with
opioid use were examined. Analysis of variance (ANOVA) was
conducted to examine differences in opioid use between cancer
and non-cancer patients. RESULTS: The sample consisted of
43,537 patients representing 4 diagnostic categories: cancer
(46%); heart diagnoses (13%); lung diagnoses excluding lung
cancer (7%); and other (33%). Half (n = 21,767 patients) were
dispensed 1 or more opioids during their hospice stay. For these
patients, the ADOE ranged from 0.03 to 15,305 (mean = 47.0;
SD = 140.0). There was a signiﬁcant inverse correlation (p <
0.0001) between opioid use and age, and male patients were dis-
pensed more opioids (mean = 50.2 ADOE) than females (mean
= 44.1 ADOE, p < 0.05). There were no differences in opioid
use by race, hospice region, or hospice size. ANOVA testing
revealed that opioid use among patients with a hospice diagno-
sis of cancer differed from those without cancer (ADOE = 54.3
cancer vs. 35.0 non-cancer; p < 0.0001), and mean length of
hospice care was shorter for cancer vs. non-cancer patients (43.4
days and 55.2 days, respectively; p < 0.0001). CONCLUSIONS:
Few studies have investigated opioid use in a national hospice
population, in particular, the differences between cancer and
non-cancer patients. Signiﬁcant differences in opioid use were
noted, suggesting the need for further research on how to best
deliver hospice services for this fragile population.
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Prostate cancer is the most common cancer affecting American
men and the second leading cause of cancer deaths in the US.
African-American men have the highest prostate cancer inci-
dence and mortality rates in the world. OBJECTIVE: The
purpose was to investigate differences across racial groups in 
the disease state and treatment of men hospitalized for prostate
cancer. METHODS: Data Source—Florida Agency for Health
Care Administration (AHCA) hospital discharge data for 2002.
Each record represents a patient discharge and includes patient
demographics, diagnoses, procedures and charges for the stay.
Study population includes all patients under 80 years old with 
a primary diagnosis of prostate cancer hospitalized in Florida
during 2002. Analysis: SPSS was used to compare procedures,
co-morbidities, and patient outcomes of discharge status, length-
of-stay and total charges. Chi-Square tests and ANOVA were
used to detect signiﬁcant differences across racial groups.
RESULTS: A total of 5444 men were included in the analysis.
The average age was 64.5 years, with 73% of the patients 
Caucasian, 12% African-American, 11% Hispanic and 4%
other races. Average length of stay was 3.3 days, costing about
$23,000 per stay. Medicare was the primary payer for over 47%
of the hospitalizations. Prostatectomy was performed on 81.5%
of the patients with no signiﬁcant differences across racial
groups. Hypertension was reported in 41.5% of the patients,
occurring signiﬁcantly more in African American patients. On
average, African Americans had signiﬁcantly higher hospital
charges and length of stay, yet were signiﬁcantly younger than
Caucasians. Finally, African Americans were more likely to have
a discharge status of death than any other racial group. CON-
CLUSIONS: African American men hospitalized for prostate
cancer have very different experiences than men of other racial
groups. Further research is necessary to determine why this dis-
parity occurs and how it might be attenuated.
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OBJECTIVE: Colorectal Cancer (CRC), when detected early,
can be treated, reducing morbidity and mortality. In 1997, the
American Cancer Society issued major revisions for CRC screen-
ing guidelines to include new research ﬁndings and improve-
ments in testing accuracy. Research suggests that physicians do
not always follow CRC screening guidelines; lack of knowledge
about appropriate guidelines or guideline changes is often cited
as a barrier. The aim of this systematic review was to examine
studies measuring physician CRC screening knowledge and
related practice patterns. METHODS: A tiered systematic search
(1997–2004) was conducted for studies, irrespective of design,
which were published in peer-reviewed journals through
MEDLINE, Academic Search Elite, CancerLit, CINAHL, and
PsycINFO databases. Tier 1 search combined keywords “knowl-
edge” and “physicians” with “colorectal cancer screening”
which identiﬁed 48 studies. Tier 2 search combined keywords
“practice patterns” and “physicians” with “colorectal cancer
screening” which identiﬁed 52 studies. Tier 3 was a review of
papers identiﬁed in Tiers 1 and 2. Ten studies meeting the
“knowledge” and “practice patterns” inclusion criteria were
retained. RESULTS: Studies reported that a signiﬁcant percent-
age of physicians were performing Fecal Occult Blood Test on
stool samples obtained from Digital Rectal Examination, a
method that often produces false results. Roughly half of physi-
cians were reported to be performing screening tests without
